The tour of England poses significant challenges for Team India, particularly for the batsmen, as it has from 1932 to 2022, and this time will be no different.

Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 weeks with ...

Fifteen years ago, I was on board a cruise ship whose captain was a friend of ours. I was doing research on economic risk in ...

The global surge in diabetes cases is a key factor propelling the artificial pancreas device market, as a larger patient base fuels the need for effe ...